International Journal of
Reproductive Biomedicine
Sun, Dec 22, 2024
[Archive]
Volume 12, Issue 12 (12-2014)
IJRM 2014, 12(12): 793-798 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Saghafi N, Mohammadzadeh Vatanchi A, Tara F, Pourali L, Dadgar S. Evaluation of selected thrombotic factors among pregnant women with preeclampsia and normal pregnant women. IJRM 2014; 12 (12) :793-798
URL: http://ijrm.ir/article-1-502-en.html
URL: http://ijrm.ir/article-1-502-en.html
Nafiseh Saghafi1 
, Atieh Mohammadzadeh Vatanchi * 2, Fatemeh Tara3 , Leila Pourali1 , Salmeh Dadgar4
, Atieh Mohammadzadeh Vatanchi * 2, Fatemeh Tara3 , Leila Pourali1 , Salmeh Dadgar4
1- Department of Obstetrics and Gynecology, Qaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
2- Department of Obstetrics and Gynecology, Mashhad University of Medical Sciences, Mashhad, Iran ,atiyeh.vatanchi81@gmail.com
3- Department of Obstetrics and Gynecology, Om-albanin Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
4- Department of Obstetrics and Gynecology, Mashhad University of Medical Sciences, Mashhad, Iran
2- Department of Obstetrics and Gynecology, Mashhad University of Medical Sciences, Mashhad, Iran ,
3- Department of Obstetrics and Gynecology, Om-albanin Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
4- Department of Obstetrics and Gynecology, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract: (3662 Views)
Background: Preeclampsia is one of the common complications during pregnancy with considerable maternal and fetal mortality and morbidity. Hypercoagulability due to thrombophilic factors is discussed as the etiology involved in this disease.
Objective: The aim of this study was to evaluate selected thrombotic factors among pregnant women with preeclampsia and normal pregnant women.
Materials and Methods: This case-control study was performed on 200 pregnant women at third trimester of pregnancy between 2012 and 2013. 100 pregnant women admitted to Qaem and Imam Reza hospitals of Mashhad, due to preeclampsia, were selected as case group and 100 pregnant women without preeclampsia referred to OB/GYN clinic of these hospitals as control group. Blood samples were taken from two groups for evaluation of the coagulation factors including factor V Leiden, protein C, protein S, antithrombin III, anti-cardiolipin antibodies, and lupus anticoagulant antibodies.
Results: Two groups were not significantly different in terms of maternal age and parity (p>0.05). Levels of factor V Leiden, protein C, protein S, antithrombin III, anti-cardiolipin antibodies and lupus anticoagulant antibodies were compared between two groups. The number of patients with abnormal factor V Leiden and protein C was significantly higher in case group than in the control group (p<0.01 respectively), but other factors were not significant different between two groups. Thrombophilia disorders were significantly more in case group compared to control (p<0.001).
Conclusion: The risk of thrombophilia disorders is higher in preeclamptic patients than normal pregnant women.
Objective: The aim of this study was to evaluate selected thrombotic factors among pregnant women with preeclampsia and normal pregnant women.
Materials and Methods: This case-control study was performed on 200 pregnant women at third trimester of pregnancy between 2012 and 2013. 100 pregnant women admitted to Qaem and Imam Reza hospitals of Mashhad, due to preeclampsia, were selected as case group and 100 pregnant women without preeclampsia referred to OB/GYN clinic of these hospitals as control group. Blood samples were taken from two groups for evaluation of the coagulation factors including factor V Leiden, protein C, protein S, antithrombin III, anti-cardiolipin antibodies, and lupus anticoagulant antibodies.
Results: Two groups were not significantly different in terms of maternal age and parity (p>0.05). Levels of factor V Leiden, protein C, protein S, antithrombin III, anti-cardiolipin antibodies and lupus anticoagulant antibodies were compared between two groups. The number of patients with abnormal factor V Leiden and protein C was significantly higher in case group than in the control group (p<0.01 respectively), but other factors were not significant different between two groups. Thrombophilia disorders were significantly more in case group compared to control (p<0.001).
Conclusion: The risk of thrombophilia disorders is higher in preeclamptic patients than normal pregnant women.
Type of Study: Original Article |
References
1. Lydakis C, Beevers M, Beevers DG, Lip GY. The prevalence of pre-eclampsia and obstetric outcome in pregnancies of normotensive and hypertensive women attending a hospital specialist clinic. Int J Clin Pract 2000; 55: 361-367.
2. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365: 785-799. [DOI:10.1016/S0140-6736(05)71003-5]
3. Hopkins MP. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183: 1-258. [DOI:10.1016/S0002-9378(00)99785-0]
4. Leeman L, Fontaine P. Hypertensive disorders of pregnancy. Am Fam Physician 2008; 78: 93.
5. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357: 53-56. [DOI:10.1016/S0140-6736(00)03577-7]
6. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.
7. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995; 85: 1504-1508.
8. Wong F, Cox B. Proteomics Analysis of Preeclampsia, a Systematic Review of Maternal and Fetal Compartments. J Proteomics Bioinform S 2014; 10: 2. [DOI:10.4172/jpb.S10-001]
9. Dizon-Townson DS, Nelson LM, Easton K, Ward K. The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996; 175: 902-905. [DOI:10.1016/S0002-9378(96)80022-6]
10. Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P, et al. Factor V Leiden, C> T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 1997; 77: 1052-1054.
11. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340: 9-13. [DOI:10.1056/NEJM199901073400102]
12. Wang X, Bai T, Liu S, Pan H, Wang B. Association between Thrombophilia Gene Polymorphisms and Preeclampsia: A Meta-Analysis. PloS One 2014; 9: e100789.
13. Dietl J. The pathogenesis of pre-eclampsia: new aspects. J Perinat Med 2000; 28: 464-471. [DOI:10.1515/JPM.2000.063]
14. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999; 222: 222-235. [DOI:10.1046/j.1525-1373.1999.d01-139.x]
15. Middeldorp S. Thrombophilia and pregnancy complications: cause or association? J Thromb Haemost 2007; 5: 276-282.
16. Mello G, Parretti E, Marozio L, Pizzi C, Lojacono A, Frusca T, et al. Thrombophilia is significantly associated with severe preeclampsia results of a large-scale, case-controlled study. Hypertension 2005; 46: 1270-1274. [DOI:10.1161/01.HYP.0000188979.74172.4d]
17. Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome?: A systematic review. Eur J Obstet Gynecol Reprod Biol 2002; 101: 6-14. [DOI:10.1016/S0301-2115(01)00496-1]
18. Kujovich JL. Thrombophilia and pregnancy complications. Am J Obstet Gynecol 2004; 191: 412-424. [DOI:10.1016/j.ajog.2004.03.001]
19. Dizon-Townson D, Miller C, Sibai B, Spong CY, Thom E, Wendel Jr G, et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005; 106: 517-524. [DOI:10.1097/01.AOG.0000173986.32528.ca]
20. Kocher O, Cirovic C, Malynn E, Rowland CM, Bare LA, Young BA, et al. Obstetric Complications in Patients with Hereditary Thrombophilia Identified Using the LCx Microparticle Enzyme Immunoassay A Controlled Study of 5,000 Patients. Am J Clin Pathol 2007; 127: 68-75. [DOI:10.1309/JWL27GRGU71VP5QL]
21. Lin J, August P. Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 2005; 105: 182-192. [DOI:10.1097/01.AOG.0000146250.85561.e9]
22. Alfirevic Z, Mousa HA, Martlew V, Briscoe L, Perez-Casal M, Toh CH. Postnatal screening for thrombophilia in women with severe pregnancy complications. Obstet Gynecol 2001; 97: 753-759.
23. Karimi S, Yavarian M, Azinfar A, Rajaei M, Kootenaee MA. Evaluation the frequency of factor V Leiden mutation in pregnant women with preeclampsia syndrome in an Iranian population. Iran J Reprod Med 2012; 10: 59-66.
24. Facchinetti F, Marozio L, Frusca T, Grandone E, Venturini P, Tiscia GL, et al. Maternal thrombophilia and the risk of recurrence of preeclampsia. Am J Obstet Gynecol 2009; 200: 46. [DOI:10.1016/j.ajog.2008.07.032]
25. Ogawa M, Matsuda Y, Kobayashi A, Mitani M, Makino Y, Matsui H. Plasma antithrombin levels correlate with albumin and total protein in gestational hypertension and preeclampsia. Pregnancy Hypertens 2014; 4: 174-177. [DOI:10.1016/j.preghy.2014.03.004]
26. Morrison E, Miedzybrodzka Z, Campbell D, Haites N, Wilson B, Watson M, et al. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb Haemost 2002; 87: 779-785.
27. Murphy RP, Donoghue C, Nallen RJ, D'Mello M, Regan C, Whitehead AS, et al. Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy. Arterioscler Thromb Vascular Biol 2000; 20: 266-270. [DOI:10.1161/01.ATV.20.1.266]
28. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe G, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006; 132: 171-196. [DOI:10.1111/j.1365-2141.2005.05847.x]
29. Kahn SR, Platt R, McNamara H, Rozen R, Chen MF, Genest J Jr, et al. Inherited thrombophilia and preeclampsia within a multicenter cohort: the Montreal Preeclampsia Study. Am J Obstet Gynecol 2009; 200: 151. [DOI:10.1016/j.ajog.2008.09.023]
30. Livingston JC, Barton JR, Park V, Haddad B, Phillips O, Sibai BM. Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia. Am J Obstet Gynecol 2001; 185: 153-157. [DOI:10.1067/mob.2001.114691]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
